Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 16;18(1):139.
doi: 10.1186/s12889-018-5024-6.

Factors associated with HIV positive sero-status among exposed infants attending care at health facilities: a cross sectional study in rural Uganda

Affiliations

Factors associated with HIV positive sero-status among exposed infants attending care at health facilities: a cross sectional study in rural Uganda

Methuselah Muhindo Kahungu et al. BMC Public Health. .

Abstract

Background: East and South Africa contributes 59% of all pediatric HIV infections globally. In Uganda, HIV prevalence among HIV exposed infants was estimated at 5.3% in 2014. Understanding the remaining bottlenecks to elimination of mother-to-child transmission (eMTCT) is critical to accelerating efforts towards eMTCT. This study determined factors associated with HIV positive sero-status among exposed infants attending mother-baby care clinics in rural Kasese so as to inform enhancement of interventions to further reduce MTCT.

Methods: This was a cross-sectional mixed methods study. Quantitative data was derived from routine service data from the mother's HIV care card and exposed infant clinical chart. Key informant interviews were conducted with health workers and in-depth interviews with HIV infected mothers. Quantitative data was analyzed using Stata version 12. Logistic regression was used to determine factors associated with HIV sero-status. Latent content analysis was used to analyse qualitative data.

Results: Overall, 32 of the 493 exposed infants (6.5%) were HIV infected. Infants who did not receive ART prophylaxis at birth (AOR = 4.9, 95% CI: 1.901-13.051, p=0.001) and those delivered outside of a health facility (AOR = 5.1, 95% CI: 1.038 - 24.742, p = 0.045) were five times more likely to be HIV infected than those who received prophylaxis and those delivered in health facilities, respectively. Based on the qualitative findings, health system factors affecting eMTCT were long waiting time, understaffing, weak community follow up system, stock outs of Neverapine syrup and lack of HIV testing kits.

Conclusion: Increasing facility based deliveries and addressing underlying health system challenges related to staffing and availability of the required commodities may further accelerate eMTCT.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Approval to conduct this study was obtained from Makerere University School of Public Health Higher Degrees Research and Ethics Committee (HDREC). Further permission was obtained from the district health office to allow data collection from health facilities. Participants in the qualitative interviews provided written informed consent prior to the interview.

Consent for publication

There are no details on images or videos relating to study participants which would require their consent for publication.

Competing interest

We would like to declare that we have no financial or non- financial competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

Cited by

References

    1. UNAIDS . 2015 Progress report on the global plan towards the elimination of new HIV infections among children and keeping their mothers alive. Geneva: UNAIDS; 2015.
    1. WHO . PMTCT Strategic vision 2010 - 2015: Preventing mother -to-child transmission of HIV to reach the UNGASS and Millenium Development Goals. Geneva: WHO; 2010.
    1. WHO . Programmatic Update: Use of Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO; 2012.
    1. WHO . Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Geneva: WHO; 2010. - PubMed
    1. AIDSinfo. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. NIH. 2015. - PubMed

MeSH terms